Sensei Biotherapeutics Reports First Quarter 2021 Results and Provides Business Update

NEXT STORY
Checkpoint Therapeutics Announces Completion of Enrollment in the Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma
PREV STORY
CloudMD Closes Acquisition of Rxi, Providing an Established Specialty Drug Management and Patient Support Program to the Employer Market
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation

U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation NDA ...

author_avatar
NASDAQ Market News

Retrotope Appoints Rick E Winningham as Chairman of Board of Directors in Advance of Key Clinical Trial Data Readouts

author_avatar
NASDAQ Market News

Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics Officer

author_avatar
NASDAQ Market News